Rxi Pharmaceuticals To Present Pre-Clinial Data At 2016 ARVO Conference

Rxi is attempting to provide a topical gel whereby the patient can apply topical gel to the cornea, where the scar is, and be able to reduce scars. This is intended to reduce vision loss/blindness.